The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes

Mirjam A G Sprangers, Jeff A Sloan, Ruut Veenhoven, Charles S. Cleeland, Michele Y. Halyard, Amy P. Abertnethy, Frank Baas, Andrea M. Barsevick, Meike Bartels, Dorret I. Boomsma, Cynthia Chauhan, Amylou Dueck, Marlene H. Frost, Per Hall, Pål Klepstad, Nicholas G. Martin, Christine Miaskowski, Miriam Mosing, Benjamin Movsas, Cornelis J F Van NoordenDonald L. Patrick, Nancy L. Pedersen, Mary E. Ropka, Quiling Shi, Gen Shinozaki, Jasvinder A. Singh, Ping Yang, Ailko H. Zwinderman

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

To our knowledge, no comprehensive, interdisciplinary initiatives have been taken to examine the role of genetic variants on patient-reported quality-of-life outcomes. The overall objective of this paper is to describe the establishment of an international and interdisciplinary consortium, the GENEQOL Consortium, which intends to investigate the genetic disposition of patient-reported quality-of-life outcomes. We have identified five primary patient-reported quality-of-life outcomes as initial targets: negative psychological affect, positive psychological affect, self-rated physical health, pain, and fatigue. The first tangible objective of the GENEQOL Consortium is to develop a list of potential biological pathways, genes and genetic variants involved in these quality-of-life outcomes, by reviewing current genetic knowledge. The second objective is to design a research agenda to investigate and validate those genes and genetic variants of patient-reported quality-of-life outcomes, by creating large datasets. During its first meeting, the Consortium has discussed draft summary documents addressing these questions for each patient-reported quality-of-life outcome. A summary of the primary pathways and robust findings of the genetic variants involved is presented here. The research agenda outlines possible research objectives and approaches to examine these and new quality-of-life domains. Intriguing questions arising from this endeavor are discussed. Insight into the genetic versus environmental components of patient-reported quality-of-life outcomes will ultimately allow us to explore new pathways for improving patient care. If we can identify patients who are susceptible to poor quality of life, we will be able to better target specific clinical interventions to enhance their quality of life and treatment outcomes.

Original languageEnglish (US)
Pages (from-to)301-311
Number of pages11
JournalTwin Research and Human Genetics
Volume12
Issue number3
DOIs
StatePublished - Jun 2009

Fingerprint

Quality of Life
Psychology
Research
Genes
Fatigue
Patient Care
Research Design
Pain
Health

Keywords

  • Fatigue
  • Genetic disposition
  • Pain
  • Quality of life
  • Self-rated health

ASJC Scopus subject areas

  • Genetics(clinical)
  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health

Cite this

The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. / Sprangers, Mirjam A G; Sloan, Jeff A; Veenhoven, Ruut; Cleeland, Charles S.; Halyard, Michele Y.; Abertnethy, Amy P.; Baas, Frank; Barsevick, Andrea M.; Bartels, Meike; Boomsma, Dorret I.; Chauhan, Cynthia; Dueck, Amylou; Frost, Marlene H.; Hall, Per; Klepstad, Pål; Martin, Nicholas G.; Miaskowski, Christine; Mosing, Miriam; Movsas, Benjamin; Van Noorden, Cornelis J F; Patrick, Donald L.; Pedersen, Nancy L.; Ropka, Mary E.; Shi, Quiling; Shinozaki, Gen; Singh, Jasvinder A.; Yang, Ping; Zwinderman, Ailko H.

In: Twin Research and Human Genetics, Vol. 12, No. 3, 06.2009, p. 301-311.

Research output: Contribution to journalArticle

Sprangers, MAG, Sloan, JA, Veenhoven, R, Cleeland, CS, Halyard, MY, Abertnethy, AP, Baas, F, Barsevick, AM, Bartels, M, Boomsma, DI, Chauhan, C, Dueck, A, Frost, MH, Hall, P, Klepstad, P, Martin, NG, Miaskowski, C, Mosing, M, Movsas, B, Van Noorden, CJF, Patrick, DL, Pedersen, NL, Ropka, ME, Shi, Q, Shinozaki, G, Singh, JA, Yang, P & Zwinderman, AH 2009, 'The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes', Twin Research and Human Genetics, vol. 12, no. 3, pp. 301-311. https://doi.org/10.1375/twin.12.3.301
Sprangers, Mirjam A G ; Sloan, Jeff A ; Veenhoven, Ruut ; Cleeland, Charles S. ; Halyard, Michele Y. ; Abertnethy, Amy P. ; Baas, Frank ; Barsevick, Andrea M. ; Bartels, Meike ; Boomsma, Dorret I. ; Chauhan, Cynthia ; Dueck, Amylou ; Frost, Marlene H. ; Hall, Per ; Klepstad, Pål ; Martin, Nicholas G. ; Miaskowski, Christine ; Mosing, Miriam ; Movsas, Benjamin ; Van Noorden, Cornelis J F ; Patrick, Donald L. ; Pedersen, Nancy L. ; Ropka, Mary E. ; Shi, Quiling ; Shinozaki, Gen ; Singh, Jasvinder A. ; Yang, Ping ; Zwinderman, Ailko H. / The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. In: Twin Research and Human Genetics. 2009 ; Vol. 12, No. 3. pp. 301-311.
@article{fa6cd987e0e74ae8b355f976a2a7712a,
title = "The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes",
abstract = "To our knowledge, no comprehensive, interdisciplinary initiatives have been taken to examine the role of genetic variants on patient-reported quality-of-life outcomes. The overall objective of this paper is to describe the establishment of an international and interdisciplinary consortium, the GENEQOL Consortium, which intends to investigate the genetic disposition of patient-reported quality-of-life outcomes. We have identified five primary patient-reported quality-of-life outcomes as initial targets: negative psychological affect, positive psychological affect, self-rated physical health, pain, and fatigue. The first tangible objective of the GENEQOL Consortium is to develop a list of potential biological pathways, genes and genetic variants involved in these quality-of-life outcomes, by reviewing current genetic knowledge. The second objective is to design a research agenda to investigate and validate those genes and genetic variants of patient-reported quality-of-life outcomes, by creating large datasets. During its first meeting, the Consortium has discussed draft summary documents addressing these questions for each patient-reported quality-of-life outcome. A summary of the primary pathways and robust findings of the genetic variants involved is presented here. The research agenda outlines possible research objectives and approaches to examine these and new quality-of-life domains. Intriguing questions arising from this endeavor are discussed. Insight into the genetic versus environmental components of patient-reported quality-of-life outcomes will ultimately allow us to explore new pathways for improving patient care. If we can identify patients who are susceptible to poor quality of life, we will be able to better target specific clinical interventions to enhance their quality of life and treatment outcomes.",
keywords = "Fatigue, Genetic disposition, Pain, Quality of life, Self-rated health",
author = "Sprangers, {Mirjam A G} and Sloan, {Jeff A} and Ruut Veenhoven and Cleeland, {Charles S.} and Halyard, {Michele Y.} and Abertnethy, {Amy P.} and Frank Baas and Barsevick, {Andrea M.} and Meike Bartels and Boomsma, {Dorret I.} and Cynthia Chauhan and Amylou Dueck and Frost, {Marlene H.} and Per Hall and P{\aa}l Klepstad and Martin, {Nicholas G.} and Christine Miaskowski and Miriam Mosing and Benjamin Movsas and {Van Noorden}, {Cornelis J F} and Patrick, {Donald L.} and Pedersen, {Nancy L.} and Ropka, {Mary E.} and Quiling Shi and Gen Shinozaki and Singh, {Jasvinder A.} and Ping Yang and Zwinderman, {Ailko H.}",
year = "2009",
month = "6",
doi = "10.1375/twin.12.3.301",
language = "English (US)",
volume = "12",
pages = "301--311",
journal = "Twin Research and Human Genetics",
issn = "1832-4274",
publisher = "Australian Academic Press",
number = "3",

}

TY - JOUR

T1 - The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes

AU - Sprangers, Mirjam A G

AU - Sloan, Jeff A

AU - Veenhoven, Ruut

AU - Cleeland, Charles S.

AU - Halyard, Michele Y.

AU - Abertnethy, Amy P.

AU - Baas, Frank

AU - Barsevick, Andrea M.

AU - Bartels, Meike

AU - Boomsma, Dorret I.

AU - Chauhan, Cynthia

AU - Dueck, Amylou

AU - Frost, Marlene H.

AU - Hall, Per

AU - Klepstad, Pål

AU - Martin, Nicholas G.

AU - Miaskowski, Christine

AU - Mosing, Miriam

AU - Movsas, Benjamin

AU - Van Noorden, Cornelis J F

AU - Patrick, Donald L.

AU - Pedersen, Nancy L.

AU - Ropka, Mary E.

AU - Shi, Quiling

AU - Shinozaki, Gen

AU - Singh, Jasvinder A.

AU - Yang, Ping

AU - Zwinderman, Ailko H.

PY - 2009/6

Y1 - 2009/6

N2 - To our knowledge, no comprehensive, interdisciplinary initiatives have been taken to examine the role of genetic variants on patient-reported quality-of-life outcomes. The overall objective of this paper is to describe the establishment of an international and interdisciplinary consortium, the GENEQOL Consortium, which intends to investigate the genetic disposition of patient-reported quality-of-life outcomes. We have identified five primary patient-reported quality-of-life outcomes as initial targets: negative psychological affect, positive psychological affect, self-rated physical health, pain, and fatigue. The first tangible objective of the GENEQOL Consortium is to develop a list of potential biological pathways, genes and genetic variants involved in these quality-of-life outcomes, by reviewing current genetic knowledge. The second objective is to design a research agenda to investigate and validate those genes and genetic variants of patient-reported quality-of-life outcomes, by creating large datasets. During its first meeting, the Consortium has discussed draft summary documents addressing these questions for each patient-reported quality-of-life outcome. A summary of the primary pathways and robust findings of the genetic variants involved is presented here. The research agenda outlines possible research objectives and approaches to examine these and new quality-of-life domains. Intriguing questions arising from this endeavor are discussed. Insight into the genetic versus environmental components of patient-reported quality-of-life outcomes will ultimately allow us to explore new pathways for improving patient care. If we can identify patients who are susceptible to poor quality of life, we will be able to better target specific clinical interventions to enhance their quality of life and treatment outcomes.

AB - To our knowledge, no comprehensive, interdisciplinary initiatives have been taken to examine the role of genetic variants on patient-reported quality-of-life outcomes. The overall objective of this paper is to describe the establishment of an international and interdisciplinary consortium, the GENEQOL Consortium, which intends to investigate the genetic disposition of patient-reported quality-of-life outcomes. We have identified five primary patient-reported quality-of-life outcomes as initial targets: negative psychological affect, positive psychological affect, self-rated physical health, pain, and fatigue. The first tangible objective of the GENEQOL Consortium is to develop a list of potential biological pathways, genes and genetic variants involved in these quality-of-life outcomes, by reviewing current genetic knowledge. The second objective is to design a research agenda to investigate and validate those genes and genetic variants of patient-reported quality-of-life outcomes, by creating large datasets. During its first meeting, the Consortium has discussed draft summary documents addressing these questions for each patient-reported quality-of-life outcome. A summary of the primary pathways and robust findings of the genetic variants involved is presented here. The research agenda outlines possible research objectives and approaches to examine these and new quality-of-life domains. Intriguing questions arising from this endeavor are discussed. Insight into the genetic versus environmental components of patient-reported quality-of-life outcomes will ultimately allow us to explore new pathways for improving patient care. If we can identify patients who are susceptible to poor quality of life, we will be able to better target specific clinical interventions to enhance their quality of life and treatment outcomes.

KW - Fatigue

KW - Genetic disposition

KW - Pain

KW - Quality of life

KW - Self-rated health

UR - http://www.scopus.com/inward/record.url?scp=67249137495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67249137495&partnerID=8YFLogxK

U2 - 10.1375/twin.12.3.301

DO - 10.1375/twin.12.3.301

M3 - Article

C2 - 19456223

AN - SCOPUS:67249137495

VL - 12

SP - 301

EP - 311

JO - Twin Research and Human Genetics

JF - Twin Research and Human Genetics

SN - 1832-4274

IS - 3

ER -